Zacks: Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Given $24.75 Consensus Target Price by Brokerages

Shares of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) have earned a consensus broker rating score of 1.00 (Strong Buy) from the four analysts that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy rating.

Brokers have set a 1-year consensus price objective of $24.75 for the company and are predicting that the company will post ($0.28) earnings per share for the current quarter, according to Zacks. Zacks has also given Verona Pharma PLC American Depositary Share an industry rank of 123 out of 265 based on the ratings given to related companies.

A number of equities analysts have weighed in on VRNA shares. Wedbush started coverage on shares of Verona Pharma PLC American Depositary Share in a research note on Monday, May 22nd. They set an “outperform” rating and a $25.00 price target on the stock. Jefferies Group LLC reaffirmed a “buy” rating and set a $26.00 price target on shares of Verona Pharma PLC American Depositary Share in a research note on Monday, May 22nd. Stifel Nicolaus started coverage on shares of Verona Pharma PLC American Depositary Share in a research note on Monday, May 22nd. They set a “buy” rating and a $22.00 price target on the stock. SunTrust Banks, Inc. started coverage on shares of Verona Pharma PLC American Depositary Share in a research note on Monday, May 22nd. They set a “buy” rating and a $26.00 price target on the stock. Finally, Zacks Investment Research raised shares of Verona Pharma PLC American Depositary Share from a “hold” rating to a “buy” rating and set a $14.00 price target on the stock in a research note on Tuesday, July 25th.

Shares of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) opened at 12.28 on Wednesday. The stock’s market cap is $78.84 million. Verona Pharma PLC American Depositary Share has a 12 month low of $11.03 and a 12 month high of $17.50. The firm has a 50-day moving average price of $14.21 and a 200-day moving average price of $14.01.

TRADEMARK VIOLATION NOTICE: “Zacks: Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Given $24.75 Consensus Target Price by Brokerages” was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/08/12/zacks-verona-pharma-plc-american-depositary-share-nasdaqvrna-given-24-75-consensus-target-price-by-brokerages-updated.html.

Get a free copy of the Zacks research report on Verona Pharma PLC American Depositary Share (VRNA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Verona Pharma PLC American Depositary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma PLC American Depositary Share and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply